Heyu Biological Technology Corporation (HYBT) financial statements (2021 and earlier)

Company profile

Business Address 4TH FLOOR, NO.10 BUILDING, XINGLIN BAY
XIAMEN CITY, FUJIAN PROVINCE, 361022
State of Incorp. NV
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 9638  6091,929
Cash and cash equivalents 9638  6091,929
Receivables 8421  1,081338
Inventory, net of allowances, customer advances and progress billings 422   2023
Inventory 422   2023
Prepaid expense 48     
Other undisclosed current assets     5779
Total current assets: 64959  1,7682,369
Noncurrent Assets
Operating lease, right-of-use asset 203
Property, plant and equipment     149
Intangible assets, net (including goodwill)     1,9461,946
Goodwill     1,9461,946
Restricted cash and investments     300121
Deferred costs     6130
Other undisclosed noncurrent assets     55
Total noncurrent assets: 203   2,3262,111
TOTAL ASSETS: 85259  4,0944,480
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 111013 250243
Accounts payable 81   5148
Accrued liabilities 31   149146
Employee-related liabilities     5049
Taxes payable 00    
Other undisclosed accounts payable and accrued liabilities   13   
Deferred revenue 431
Debt 31   2526
Due to related parties 431 41   
Deferred revenue and credits  16962
Other undisclosed current liabilities 444296  (50)(49)
Total current liabilities: 1,44829654 394281
Noncurrent Liabilities
Long-term debt and lease obligation 173     
Operating lease, liability 173
Total noncurrent liabilities: 173     
Total liabilities: 1,62029654 394281
Stockholders' equity
Stockholders' equity attributable to parent, including: (716)(237)(54) 3,7004,199
Common stock 1,0321,141150505050
Additional paid in capital 17,14917,14917,97018,07018,07018,070
Accumulated other comprehensive income (loss) 123(18,174)(18,119)  
Accumulated deficit (18,910)(18,421)  (14,419)(13,921)
Other undisclosed stockholders' equity attributable to parent  (109)    
Stockholders' equity attributable to noncontrolling interest (52)     
Total stockholders' equity: (768)(237)(54) 3,7004,199
TOTAL LIABILITIES AND EQUITY: 85259  4,0944,480

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2014
12/31/2013
Revenues 164  1886,5781,664
Revenue, net 1886,5781,664
Cost of revenue (84)  (70)(4,857)(728)
Cost of goods and services sold    (70)  
Gross profit: 80  1181,722936
Operating expenses (618)(248)(54)(406)(2,231)(1,673)
Operating loss: (538)(248)(54)(288)(509)(737)
Nonoperating income (expense) (2)  13011(449)
Interest and debt expense    (1)  
Loss from continuing operations before equity method investments, income taxes: (540)(248)(54)(159)(499)(1,186)
Loss from equity method investments      (211)
Other undisclosed income from continuing operations before income taxes      211
Loss from continuing operations before income taxes: (540)(248)(54)(159)(499)(1,186)
Income tax benefit      93
Loss from continuing operations: (540)(248)(54)(159)(499)(1,093)
Loss from discontinued operations    (159)  
Loss before gain (loss) on sale of properties: (540)(248)(54)(317)(499)(1,093)
Other undisclosed net income    159  
Net loss: (540)(248)(54)(159)(499)(1,093)
Net income attributable to noncontrolling interest 52     
Other undisclosed net loss attributable to parent      (2,589)
Net loss available to common stockholders, diluted: (488)(248)(54)(159)(499)(3,682)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2014
12/31/2013
Net loss: (540)(248)(54)(159)(499)(1,093)
Other comprehensive income (loss) 10(3)    
Other undisclosed comprehensive income 52     
Comprehensive loss: (478)(250)(54)(159)(499)(1,093)
Comprehensive loss, net of tax, attributable to noncontrolling interest (0)     
Comprehensive loss, net of tax, attributable to parent: (479)(250)(54)(159)(499)(1,093)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: